DE BACKER MARIANNE (Chief Executive Officer) sold 1.8% of their position (19.04K shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $141.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/24/2026ACC: 0001628280-26-011327
DirectorOfficer· Chief Executive Officer
Since Feb 2026
+835.96K
Net shares
Net buyer
$141.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
855K acquired · 19.04K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+285K
Price / share
—
Trade value
—
% of position
37.0%
2/22/2026
769.50K→1.05M
Common Stock
Direct
Shares
−19.04K
Price / share
$7.45
Trade value
$141.89K
% of position
1.8%
2/23/2026
1.05M→1.04M
Total
Net shares
+265.96K
Net value
-$141.89K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/22/2026 | A · Award | +285K | — | — | 37.0% | 769.50K | 1.05M |
| Common Stock Direct | 2/23/2026 | S · Sale | −19.04K | $7.45 | $141.89K | 1.8% | 1.05M | 1.04M |
| Total | +265.96K | -$141.89K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
570K shares
Shares
+570K
Strike price
7.56
Held after
570K
Exercisable
—
2/22/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock570K shares | 2/22/2026 | A · Award | +570K | 7.56 | — | 570K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned53.12K
Total
53.12K indirect53.12K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 53.12K | Indirect |
| Total | 53.12K | 53.12K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported